ECC 2015 | Molecular drivers of metastatic disease in breast cancer
Giuseppe Curigliano
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, from Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer may have important clinical implications, including for the identification of biomarkers in disease progression.
Related videos
3:14
How to manage elderly patients on immunotherapy
Matti Aapro
2:30
Highlighting a subset of TNBC for targeted therapy
Adrian Harris
2:47
Current treatment landscape of triple negative breast cancer
Adrian Harris
1:26
Breast cancer driver mutations in Saudi Arabia
Ahmed Saadeddin
2:15
Outlook for HR+/HER2- advanced breast cancer treatment
Ahmed Saadeddin
